Piper Sandler Reaffirms Neutral Rating for Xencor (NASDAQ:XNCR) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Xencor (NASDAQ:XNCR – Get Free Report) posted its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.31) earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.67), Briefing.com reports. The business had revenue of $44.70 million during the quarter, compared to the consensus estimate of $77.63 million. Xencor had a […]
Xencor (NASDAQ:XNCR – Get Free Report) announced its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.31) EPS for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.67), Briefing.com reports. The firm had revenue of $44.70 million during the quarter, compared to analyst estimates of $77.63 million. Xencor had a negative net margin […]
Xencor (NASDAQ:XNCR) Issues Quarterly Earnings Results themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com lowered shares of Xencor (NASDAQ:XNCR – Free Report) from a hold rating to a sell rating in a research report released on Thursday morning. XNCR has been the topic of a number of other research reports. Royal Bank of Canada cut their price objective on shares of Xencor from $36.00 to $32.00 and set […]